82_FR_41219 82 FR 41053 - Importer of Controlled Substances Application: Fresenius Kabi USA, LLC

82 FR 41053 - Importer of Controlled Substances Application: Fresenius Kabi USA, LLC

DEPARTMENT OF JUSTICE
Drug Enforcement Administration

Federal Register Volume 82, Issue 166 (August 29, 2017)

Page Range41053-41053
FR Document2017-18312

Federal Register, Volume 82 Issue 166 (Tuesday, August 29, 2017) 
[Federal Register Volume 82, Number 166 (Tuesday, August 29, 2017)]
[Notices]
[Page 41053]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-18312]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: Fresenius Kabi 
USA, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.34(a) on or before September 28, 2017. Such persons may also file 
a written request for a hearing on the application pursuant to 21 CFR 
1301.43 on or before September 28, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.34(a), this is notice that on June 
5, 2017, Fresenius Kabi USA, LLC, 3159 Staley Road, Grand Island, New 
York 14072 applied to be registered as an importer of remifentanil 
(9739), a basic class of controlled substance listed in schedule II.
    The company plans to import the listed controlled substance for 
product development and preparation of stability batches.

    Dated: August 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-18312 Filed 8-28-17; 8:45 am]
 BILLING CODE 4410-09-P

Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices 41053 (approximately $500); for a total of 205–1810. Persons with mobility DATES: Registered bulk manufacturers of $138,188. We have not identified any impairments who will need special the affected basic classes, and other non-hour cost burdens associated assistance in gaining access to the applicants therefore, may file written with this collection of information. Commission should contact the Office comments on or objections to the Abstract: This notice concerns the of the Secretary at 202–205–2000. issuance of the proposed registration in paperwork requirements of 30 CFR 250, General information concerning the accordance with 21 CFR 1301.34(a) on Subpart M, Unitization, and related Commission may also be obtained by or before September 28, 2017. Such documents. The BSEE must approve any accessing its internet server (https:// persons may also file a written request lessee’s proposal to enter an agreement www.usitc.gov). The public record for for a hearing on the application to unitize operations under two or more this review may be viewed on the pursuant to 21 CFR 1301.43 on or before leases and for modifications when Commission’s electronic docket (EDIS) September 28, 2017. warranted. We use the information to at https://edis.usitc.gov. For further information concerning ADDRESSES: Written comments should ensure that operations under the the conduct of this review and rules of be sent to: Drug Enforcement proposed unit agreement will result in general application, consult the Administration, Attention: DEA Federal preventing waste, conserving natural Commission’s Rules of Practice and Register Representative/DRW, 8701 resources, and protecting correlative Procedure, part 201, subparts A through Morrissette Drive, Springfield, Virginia rights including the government’s E (19 CFR part 201), and part 207, 22152. All requests for hearing must be interests. subparts A, D, E, and F (19 CFR part sent to: Drug Enforcement The authorities for this action are the 207). Administration, Attn: Administrator, Outer Continental Shelf Lands Act 8701 Morrissette Drive, Springfield, (OCSLA, 43 U.S.C. 1334), the Federal SUPPLEMENTARY INFORMATION: On August Virginia 22152. All request for hearing Oil and Gas Royalty Management Act 4, 2017, the Commission determined should also be sent to: (1) Drug (FOGRMA, 30 U.S.C. 1751), the that it would proceed to a full review in Enforcement Administration, Attn: Independent Offices Appropriations Act the subject five-year review pursuant to Hearing Clerk/LJ, 8701 Morrissette (IOAA, 31 U.S.C. 9701), and the section 751(c) of the Tariff Act of 1930 Drive, Springfield, Virginia 22152; and Paperwork Reduction Act of 1995 (44 (19 U.S.C. 1675(c)). In response to the (2) Drug Enforcement Administration, U.S.C. 3501, et seq.). Commission’s notice of institution (82 Attn: DEA Federal Register Dated: July 21, 2017. FR 20381, May 1, 2017), the Representative/DRW, 8701 Morrissette Doug Morris, Commission found that the domestic Drive, Springfield, Virginia 22152. Chief, Office of Offshore Regulatory Programs. interested party group response was adequate and the respondent interested SUPPLEMENTARY INFORMATION: The [FR Doc. 2017–18264 Filed 8–28–17; 8:45 am] party group response was inadequate. Attorney General has delegated his BILLING CODE 4310–VH–P authority under the Controlled The Commission also found that other circumstances warranted conducting a Substances Act to the Administrator of full review.1 A record of the the Drug Enforcement Administration INTERNATIONAL TRADE Commissioners’ votes, the (DEA), 28 CFR 0.100(b). Authority to COMMISSION Commission’s statement on adequacy, exercise all necessary functions with [Investigation No. 731–TA–891 (Third and any individual Commissioner’s respect to the promulgation and Review)] statements will be available from the implementation of 21 CFR part 1301, Office of the Secretary and at the incident to the registration of Foundry Coke From China: Notice of Commission’s Web site. manufacturers, distributors, dispensers, Commission Determination To importers, and exporters of controlled Authority: This review is being conducted Conduct a Full Five-Year Review under authority of title VII of the Tariff Act substances (other than final orders in of 1930; this notice is published pursuant to connection with suspension, denial, or AGENCY: United States International section 207.62 of the Commission’s rules. revocation of registration) has been Trade Commission. redelegated to the Assistant By order of the Commission. ACTION: Notice. Administrator of the DEA Diversion Issued: August 23, 2017. Control Division (‘‘Assistant SUMMARY: The Commission hereby gives Katherine M. Hiner, Administrator’’) pursuant to section 7 of notice that it will proceed with a full Supervisory Attorney. 28 CFR part 0, appendix to subpart R. review pursuant to the Tariff Act of [FR Doc. 2017–18227 Filed 8–28–17; 8:45 am] 1930 to determine whether revocation of In accordance with 21 CFR BILLING CODE 7020–02–P the antidumping duty order on foundry 1301.34(a), this is notice that on June 5, coke from China would be likely to lead 2017, Fresenius Kabi USA, LLC, 3159 to continuation or recurrence of material Staley Road, Grand Island, New York DEPARTMENT OF JUSTICE 14072 applied to be registered as an injury within a reasonably foreseeable time. A schedule for the review will be Drug Enforcement Administration importer of remifentanil (9739), a basic established and announced at a later class of controlled substance listed in [Docket No. DEA–392] schedule II. date. Importer of Controlled Substances The company plans to import the DATES: August 4, 2017. Application: Fresenius Kabi USA, LLC listed controlled substance for product FOR FURTHER INFORMATION CONTACT: Abu sradovich on DSK3GMQ082PROD with NOTICES development and preparation of B. Kanu (202–205–2597), Office of ACTION: Notice of application. stability batches. Investigations, U.S. International Trade Commission, 500 E Street SW., Dated: August 21, 2017. Washington, DC 20436. Hearing- 1 Vice Chairman Johanson and Commissioner Demetra Ashley, Broadbent voted to conduct a full review of the Acting Assistant Administrator. impaired persons can obtain order. Chairman Schmidtlein and Commissioner information on this matter by contacting Williamson voted to conduct an expedited review [FR Doc. 2017–18312 Filed 8–28–17; 8:45 am] the Commission’s TDD terminal on 202– of the order. BILLING CODE 4410–09–P VerDate Sep<11>2014 18:45 Aug 28, 2017 Jkt 241001 PO 00000 Frm 00072 Fmt 4703 Sfmt 9990 E:\FR\FM\29AUN1.SGM 29AUN1


Document Created: 2017-08-29 01:57:58
Document Modified: 2017-08-29 01:57:58
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice of application.
DatesRegistered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before September 28, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before September 28, 2017.
FR Citation82 FR 41053 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR